India has seen a dip in Active cases as daily recoveries continue to rise than daily New Cases with a rise in death. As the Active cases still stand to 32,26,719 shortage of medical supplies continues to report in many states.
Citing many requests on shortage of essential drugs Minister of State Mansukh Mandaviya today assured that the Government is monitoring the supply of each COVID-19 Essential Drug. All drugs used in the management of COVID-19 are now available in India by ramping up production and increasing the imports.
The availability of these drugs is being monitored by implementing three-pronged strategy of Supply Chain Management, Demand Side Management and Affordability.
CDSCO and NPPA are coordinating with manufacturers to enhance production and getting data about current stock, current capacities, Projected production for the May, 2021.
Number of plants producing Remdesivir increased from 20 to 60 resulting in 3 times more availability in just 25 days. Production ramped up 10 times, from 10 lakhs vials/month in April to 1 crore/month in May.
It is made available in the country by importing 20 times more than what was being done in normal times.
Dexamethasone 0.5 mg tablets:
Production enhanced from 6-8 times within a month. Dexamethasone Injection production ramped up almost 2 times.
Enoxaparin Injection production increased 4 times in mere one month.
Methyl Prednisolone Injection:
Production increased almost 3 times in a months time.
Ivermectin 12 mg tab production enhanced in the country by 5 times within a month from 150 lakhs in April to 770 lakhs in May, 2021.
A non-protocol drug but it is used to lower the virus load. The production increased 4 times within a month From 326.5 lakh in April, 21 to 1644 lakh in May, 21.
Amphoterecin B Injection:
Production ramped up to 3 times in a month. 3.80 lakh vials are in production and 3 lakh vials are being imported. Total 6.80 lakh vials will be available in the country.